Hubbry Logo
Sentinel surveillanceSentinel surveillanceMain
Open search
Sentinel surveillance
Community hub
Sentinel surveillance
logo
7 pages, 0 posts
0 subscribers
Be the first to start a discussion here.
Be the first to start a discussion here.
Sentinel surveillance
Sentinel surveillance
Sentinel surveillance
View on Wikipedia
from Wikipedia

Sentinel surveillance is monitoring of rate of occurrence of specific diseases and conditions through a voluntary network of doctors, laboratories and public health departments with a view to assess the stability or change in health levels of a population.[1] It also describes the study of disease rates in a specific cohort such as a geographic area or subgroup to estimate trends in a larger population.[1] In zoonotic diseases, sentinel surveillance may be in a host species.[2]

Purpose

[edit]

A sentinel surveillance system is used to obtain data about a particular disease that cannot be obtained through a passive system such as summarizing standard public health reports. Data collected in a well-designed sentinel system can be used to signal trends, identify outbreaks and monitor disease burden, providing a rapid, economical alternative to other surveillance methods.[3]

Method

[edit]

Sentinel systems involve a network of reporting sites, typically doctors, laboratories and public health departments. Surveillance sites must offer:[3]

  • commitment to resource the program
  • a high probability of observing the target disease,
  • a laboratory capable of systematically testing subjects for the disease,
  • experienced, qualified staff.
  • relatively large population with easy site access

Passive surveillance

[edit]

Passive surveillance systems receive data from "all" (or as many as possible) health workers/facilities and is the most common method of tracking communicable diseases.[4] Passive surveillance does not require health authorities to stimulate reporting by reminding health care workers. Workers may receive the surveillance training in how to complete surveillance forms. Passive surveillance is often incomplete because of the limited reporting incentives.[4]

Systems

[edit]

Sentinel systems collect data on Haemophilus influenzae type b, meningococcus and pneumococcus.[3]

Because sentinel surveillance is conducted only at selected locations, it is not as appropriate for use on rare diseases or outbreaks distant from sentinel sites.[3]

COVID-19

[edit]

The state of Hawaii conducts a sentinel surveillance program for COVID-19. From March 1-April 11, 2020, Hawaii's system detected 23 cases of COVID-19 among 1,084 specimens tested (2.1%). Samples were selected to match the state's geographic and age distribution.[5] In Santa Clara, California, researchers analyzed sentinel surveillance data from March 5–14, 2020.[6] From this sample, 19 out of 226 participants (8%) had COVID-19.[6]

See also

[edit]

References

[edit]
[edit]
Revisions and contributorsEdit on WikipediaRead on Wikipedia

Sentinel surveillance

View on Grokipedia
from Grokipedia
Sentinel surveillance is a targeted epidemiological monitoring system in that relies on a predefined network of selected healthcare providers, laboratories, hospitals, or sites to report specific health events, diseases, or conditions, enabling the detection of trends, early warnings, and resource allocation without requiring comprehensive population-wide coverage. This approach contrasts with passive or active by focusing on high-quality from representative "sentinel" sites, which are chosen for their ability to generalize findings to broader populations, particularly when resources limit full-scale monitoring. The primary purpose of sentinel surveillance is to identify emerging health threats, track disease incidence and prevalence, and inform public health interventions, such as vaccine development or outbreak responses, by providing timely and cost-effective data on pathogen trends, age distributions, and risk factors. For instance, it is widely applied to vaccine-preventable diseases like influenza, where sentinel sites collect specimens for genotyping to guide annual vaccine formulations, or to monitor chronic conditions such as diabetes and obesity through primary care networks. In global contexts, networks like GeoSentinel track travel-related illnesses, including malaria, while systems in multiple countries monitor outbreaks of cholera and hepatitis. Recent adaptations have leveraged influenza sentinel platforms for monitoring SARS-CoV-2 from 2020 to 2024. Key advantages include its efficiency in supplementing routine reporting during resource constraints, yielding reliable trend data from motivated participants, and supporting advanced analyses like case-control studies for vaccine effectiveness. However, limitations arise from its restricted scope, which may overlook cases outside designated sites, and its dependence on the accuracy and representativeness of selected reporters. Overall, sentinel surveillance plays a critical role in modern by balancing depth of information with practical feasibility, enhancing for both endemic and emerging challenges.

Definition and Principles

Definition

Sentinel surveillance is a targeted form of epidemiological monitoring that utilizes a pre-selected network of reporting sites, such as clinics, laboratories, or healthcare providers, to track the incidence, trends, and outbreaks of specific diseases or conditions within a representative sample of the population. This approach relies on a limited number of committed participants who systematically report data on predefined events, allowing for efficient detection and estimation of broader population-level patterns without requiring universal coverage. Key characteristics of sentinel surveillance include voluntary participation by the selected sites, which fosters commitment and high-quality data reporting, and a deliberate focus on particular health events or conditions rather than all possible occurrences. The system emphasizes the use of standardized protocols to ensure data reliability, enabling extrapolations to larger populations through statistical methods that account for the representativeness of the network. Unlike comprehensive surveillance, it prioritizes depth and timeliness over breadth, making it particularly suitable for resource-constrained settings. Sentinel surveillance emerged in the 1980s as an efficient alternative to resource-intensive comprehensive surveillance systems, addressing the need for timely monitoring amid rising global health threats. It gained early adoption by the (WHO), particularly through its Global Programme on AIDS, which developed sentinel networks in the late 1980s to track prevalence in low- and middle-income countries using accessible sites like antenatal clinics. This foundational application highlighted its utility for infectious disease monitoring, including vaccine-preventable diseases, and laid the groundwork for its integration into broader frameworks.

Core Principles

Sentinel surveillance operates as a subset of active monitoring, relying on a network of selected sites to provide ongoing, high-quality data on health events. A foundational is representativeness, ensuring that sentinel sites are chosen to mirror the broader population's demographics, geographic distribution, and disease risk profiles. This approach allows data from a limited number of sites to be generalizable to larger areas or national levels, as seen in guidelines for selecting sites that cover diverse regions and socio-economic groups. Commitment and capacity form another core tenet, requiring participating entities—such as healthcare providers or facilities—to demonstrate reliable , trained personnel, and adherence to standardized reporting protocols. Sites must agree to consistent participation, supported by technical assistance from health authorities to maintain operational reliability. Timeliness and quality are emphasized to ensure rapid reporting, rigorous validation processes, and seamless integration with systems. This involves prioritizing electronic reporting mechanisms and regular feedback loops to verify accuracy and completeness, enabling effective responses. Ethical considerations underpin the design and operation of sentinel systems, including obtaining from participants where applicable, safeguarding data confidentiality to protect , and promoting equitable to support sites without exacerbating disparities. These principles balance benefits with individual rights, fostering trust in surveillance activities.

Purposes and Benefits

Primary Purposes

Sentinel surveillance serves as a targeted approach to monitor events in selected populations or sites, enabling early detection of outbreaks and emerging s through continuous . By focusing on representative sentinel sites, such as healthcare facilities or communities, this system identifies unusual patterns or increases in incidence before they escalate into widespread epidemics, allowing for prompt interventions. For instance, it facilitates the rapid identification of shifts in , supporting decisions on measures. A key objective is the estimation of and incidence rates, which informs policy and . Sentinel data provide reliable approximations of overall impact in a , even when comprehensive nationwide is resource-intensive, by extrapolating from monitored cohorts to broader demographics. This helps prioritize funding for prevention programs and healthcare infrastructure based on quantified morbidity and mortality trends. Sentinel surveillance also evaluates the effectiveness of interventions, including campaigns and patterns of . Through longitudinal tracking at sentinel sites, it assesses uptake, coverage, and protective against targeted diseases, guiding adjustments to strategies. Similarly, it monitors resistance trends in pathogens to inform and treatment guidelines, ensuring interventions remain viable against evolving threats. Finally, the system supports by generating high-quality, longitudinal datasets on specific conditions. These datasets enable in-depth studies on etiology, transmission dynamics, and long-term outcomes, fostering advancements in and therapeutic development without relying on ad hoc collections. The structured nature of sentinel reporting ensures suitable for peer-reviewed analyses and model-based projections.

Advantages

Sentinel surveillance systems are particularly advantageous in due to their targeted approach, which balances comprehensive monitoring with practical constraints. By concentrating efforts on a select network of healthcare facilities or providers, these systems minimize the need for universal reporting, thereby reducing logistical and financial burdens compared to exhaustive population-wide surveillance methods. This focused strategy has been shown to be more cost-effective, especially when large-scale systems prove prohibitively expensive. A key strength lies in the enhanced achieved through dedicated sentinel sites. These sites, often equipped with specialized and standardized protocols, yield more accurate, complete, and timely reports than broader passive systems, as staff are motivated by regular and integration into frameworks. For instance, programs for clinicians and personnel ensure consistent case detection and specimen collection, leading to reliable epidemiological insights that support outbreak detection and intervention planning. The flexibility of sentinel surveillance further amplifies its utility, allowing adaptation to specific diseases, geographic regions, or emerging threats without overhauling entire infrastructures. This adaptability facilitates rapid scaling during outbreaks, such as by expanding site networks or adjusting reporting criteria in response to evolving epidemiological patterns. In resource-limited settings, particularly in developing countries, sentinel systems enable effective disease monitoring without overwhelming strained health systems, leveraging existing facilities to generate sustainable for global databases like FluNet.

Methods and Implementation

Site Selection Criteria

Site selection in sentinel surveillance involves a systematic to ensure sites can effectively monitor targeted events while maintaining efficiency and representativeness. Key criteria include high patient volume to generate sufficient cases for reliable detection, such as facilities with at least 500 annual admissions for severe acute respiratory infections (), geographic diversity to cover urban, rural, and regional variations, accessibility for and , and to the target through proximity to at-risk populations or environments. These standards align with core principles of commitment, emphasizing staff and long-term stability, and capacity, focusing on like reliable reporting systems and specimen handling. The selection process begins with an initial assessment of potential sites, often shortlisting candidates from facility lists based on preliminary data on performance and . This is followed by on-site visits using standardized checklists to evaluate feasibility, including infrastructure (e.g., for specimens, ) and willingness of staff to participate. Agreements are then formalized through memoranda of understanding with local health authorities to secure , , and ongoing support, typically committing to multi-year operations with budgets around USD 40,000 per site annually. Regular evaluations, such as monthly or quarterly site visits, assess continued suitability by reviewing , case reporting rates, and changes in local to allow for site replacement if needed. Suitable site types vary by surveillance objectives; for instance, primary care clinics may be chosen for outpatient monitoring of mild illnesses, hospitals for inpatient severe cases like SARI, laboratories for pathogen confirmation, or schools for pediatric respiratory events. The emphasis is on general or community facilities that treat diverse patient groups rather than specialized centers to better reflect population-level trends. To ensure representativeness, is employed, dividing the population into strata based on factors such as urban versus rural settings, age demographics (e.g., including pediatric and geriatric care), and socioeconomic indicators to proportionally select sites that mirror national diversity. This approach minimizes bias and supports accurate incidence estimates when combined with catchment population data.

Data Collection and Analysis

In sentinel surveillance, data collection relies on standardized case definitions to ensure consistency across reporting sites, such as those for (ILI), defined as an acute respiratory with measured fever of at least 38°C and , or severe acute respiratory (SARI), which includes similar symptoms requiring hospitalization. These definitions guide the identification of reportable events by recruited healthcare providers or facilities within the network. Electronic reporting tools, including web-based portals and interoperable standards like Public Health Information Network (PHIN), Logical Observation Identifiers Names and Codes (LOINC), and (SNOMED), facilitate timely submission of case notifications and demographic details. Laboratory confirmation protocols are , involving the collection of clinical specimens—such as nasal swabs for viral testing or blood samples for serological —and subsequent processing at designated labs to verify pathogens, often provided at no cost to participants to encourage compliance. Reporting occurs on a routine basis, typically weekly, to capture ongoing trends in disease activity, with sentinel sites submitting aggregated case counts and laboratory results to central coordinators. Event-triggered reporting supplements this during outbreaks or seasonal peaks, prompting immediate notifications for rapid response, thereby balancing resource efficiency with timeliness in detecting changes in incidence. Data analysis begins with aggregation from multiple sites to form a representative sample, enabling the detection of temporal and spatial trends, such as seasonal fluctuations in respiratory illnesses. Statistical techniques, including multiplier models, extrapolate sentinel data to estimate population-level incidence by adjusting for underreporting or non-sentinel cases—for instance, deriving ratios of nonhospitalized to hospitalized influenza illnesses based on combined surveillance inputs. Visualization tools, such as interactive dashboards, present these analyses through charts and maps to aid interpretation and decision-making by public health officials. Quality control measures include automated validation checks during to flag inconsistencies, periodic audits to assess reporting completeness (which can vary from 6% to 90% across systems), and feedback loops via newsletters or direct communication to sites, ensuring ongoing accuracy and participation. These processes maintain , with countries regularly sharing validated outputs with global bodies like the for coordinated analysis.

Comparisons with Other Systems

Passive Surveillance

Passive surveillance in is a method of disease monitoring that depends on voluntary and unprompted reporting of cases by healthcare providers, laboratories, and facilities to central health authorities, without any systematic follow-up or active solicitation of data from surveillance personnel. This approach forms the backbone of many routine activities, where reports are submitted based on established protocols rather than targeted . A primary feature of passive surveillance is its low cost, as it leverages existing healthcare infrastructure and does not require dedicated personnel for data gathering, allowing for broad coverage across all reporting sites nationwide. However, the lack of incentives, reminders, or verification processes often leads to underreporting, as providers may overlook or delay submissions due to workload pressures or incomplete case recognition. It is commonly employed in reporting systems, where healthcare providers are legally required by state or local regulations to submit data on specified conditions, such as infectious diseases, to track incidence and support interventions. Unique limitations of passive surveillance include incomplete capture of mild or subclinical cases, which frequently go unreported because affected individuals do not seek care or providers do not diagnose them as notifiable. Transmission delays are also inherent, as data flow relies on manual or periodic submissions, potentially postponing outbreak detection and response efforts. In this context, sentinel surveillance can enhance passive systems by focusing resources on representative sites for more reliable trend analysis.

Active Surveillance

Active surveillance in refers to a systematic approach where authorities proactively contact healthcare providers, laboratories, or other reporting units to collect data on events, often through methods such as telephone calls, site visits, or regular follow-ups. This contrasts with passive surveillance, which relies on voluntary reporting from these entities without direct solicitation. A key feature of active surveillance is its emphasis on completeness and timeliness, as it minimizes underreporting by directly engaging sources, thereby providing more reliable data for monitoring disease trends. However, it is resource-intensive, requiring dedicated personnel, funding, and logistical coordination, which can limit its scalability for routine use. Active surveillance is particularly applied to rare diseases or during outbreaks, where exhaustive case finding is essential to capture all occurrences and inform rapid response measures. In such scenarios, it ensures comprehensive coverage across a broad network of reporting sites to estimate incidence accurately. Unlike sentinel surveillance, which concentrates on a select group of high-quality reporting sites for in-depth data, active surveillance extends to all or many units, offering wider geographic breadth but potentially less specialized detail per site.

Notable Examples

COVID-19 Applications

During the early stages of the , sentinel surveillance systems were rapidly adapted to monitor community transmission in various regions. In , the state implemented a sentinel surveillance program targeting outpatients with mild to moderate respiratory symptoms, excluding those with recent travel or severe illness. As of April 11, 2020, the program had tested 925 specimens, detecting 17 positive cases for with a positivity rate of 1.8%, which provided critical data for assessing low-level community spread and supported early containment measures such as enhanced testing and . Similarly, in , officials launched a rapid sentinel surveillance effort in collaboration with outpatient clinics to evaluate potential community transmission. Between March 5 and 14, 2020, 226 patients meeting criteria for were screened; of these, 79 were further tested for , yielding 9 positive cases (11% positivity rate). These findings confirmed widespread community circulation beyond known travel-related cases, directly informing local policies, including recommendations to cancel large gatherings on March 9 and a countywide order on March 16. Globally, sentinel surveillance was integrated with (WHO) guidelines to enhance monitoring through complementary approaches like and syndromic surveillance at selected sites. WHO recommended incorporating sampling from sentinel locations to detect trends ahead of clinical cases, alongside syndromic surveillance of in networks, to provide early warnings and guide in resource-limited settings. Post-2020, these systems facilitated assessments of COVID-19 vaccine rollout effectiveness and variant tracking. Sentinel networks enabled real-time evaluation of vaccine impact on incidence and hospitalization rates during initial deployment phases, while genomic sequencing of specimens from sentinel sites supported early detection and monitoring of variants like Delta and Omicron, informing targeted public health responses.

Influenza and Vaccine-Preventable Diseases

Sentinel surveillance plays a pivotal role in monitoring influenza through the World Health Organization's Global Influenza Surveillance and Response System (GISRS), established in 1952 to provide early warnings of viral changes and inform public health responses. As of 2024, GISRS comprises 151 National Influenza Centres across 127 countries, which collect and analyze virological and epidemiological data from sentinel sites to track circulating strains, monitor disease burden, and detect antigenic variations. This network facilitates biannual consultations where surveillance data, including antigenic characterization of isolates, guide the selection of influenza vaccine strains to match evolving viral populations. In the United States, the Influenza-Like Illness Surveillance Network (ILINet), coordinated by the Centers for Disease Control and Prevention (CDC), exemplifies national sentinel surveillance for influenza. ILINet involves approximately 3,000 outpatient healthcare providers who report weekly the total number of patient visits and those for influenza-like illness (ILI), stratified by age group, to assess seasonal trends and activity levels. These data contribute to national estimates of influenza circulation, helping to evaluate the timing and intensity of outbreaks without requiring laboratory confirmation for every case. Beyond , sentinel surveillance extends to vaccine-preventable diseases such as and , particularly in high-risk areas where routine case reporting may be incomplete. The WHO coordinates global surveillance networks that incorporate sentinel sites to detect outbreaks, estimate , and verify elimination progress, including laboratory confirmation of cases from targeted populations. For , sentinel systems in endemic or re-emerging regions monitor environmental samples and acute cases to support certification of eradication, while for , they enable rapid response and vaccination campaigns in underserved communities. Historically, within systems like GISRS has been essential for annual formulation by enabling the detection and analysis of antigenic drift, the gradual mutations in and neuraminidase proteins that reduce efficacy over time. Through ongoing virological testing of samples from sentinel providers, these systems identify dominant circulating variants, informing WHO recommendations for trivalent or quadrivalent compositions to optimize protection against seasonal epidemics. This process ensures vaccines are updated proactively, as antigenic drift necessitates revisions twice yearly for Northern and formulations.

Challenges and Limitations

Operational Challenges

Sentinel surveillance networks often face significant resource constraints, particularly in low-income regions where funding shortages limit site maintenance, staff training, and technological upgrades. In developing countries, the lack of dedicated funds forces reliance on existing , resulting in incomplete coverage and unsustainable operations, as seen in evaluations of syndromic surveillance systems in the . Similarly, the high costs of sustaining genomic surveillance platforms in low- and middle-income countries hinder long-term viability, exacerbating disparities in monitoring capabilities. These constraints undermine the cost-effectiveness of sentinel systems by increasing the risk of system collapse without external support. Participation issues further complicate operations, with declining engagement among healthcare providers and community workers due to heavy workloads and insufficient incentives, leading to high attrition rates. In resource-limited settings, frontline staff often juggle surveillance duties with clinical responsibilities, causing motivation to wane and to suffer, as evidenced in community-based efforts during crises. Attrition is particularly acute in understaffed networks, where single-point failures from or turnover disrupt reporting continuity, necessitating strategies like coordinator visits to bolster involvement. Data integration poses another operational hurdle, as linking sentinel data with national health information systems for real-time analysis is frequently impeded by incompatible formats and disparate sources. programs struggle with merging data from multiple origins, requiring extensive cleaning and transformation to enable timely insights, yet delays persist due to technical limitations. In low-resource environments, this fragmentation results in duplicate efforts and reduced analytical efficiency, preventing seamless incorporation into broader national frameworks. Ensuring consistent adherence to protocols across diverse sites demands ongoing , but resource scarcity often leaves gaps in staff and . In sentinel networks, initial and for , specimen handling, and reporting is essential, yet insufficient capacity in developing countries leads to inconsistencies and errors. Diverse geographical and institutional settings amplify these challenges, requiring tailored yet uniform approaches to maintain protocol fidelity without overwhelming local teams.

Scope Limitations

Sentinel surveillance, by design, operates within a predefined network of selected sites, inherently restricting its ability to capture the full spectrum of health events across a . This targeted approach excels in providing timely and high-quality data from representative subsets but imposes significant scope limitations, particularly in underrepresentation of rare or geographically isolated occurrences. For instance, events occurring outside sentinel sites, such as localized outbreaks in remote areas, may go undetected, necessitating statistical to estimate broader incidence, which introduces uncertainty in national or regional inferences. A key limitation arises from potential biases in , which often prioritize accessible, urban, or well-resourced facilities to ensure data reliability and feasibility. This can skew data toward populations in these areas, underestimating burdens in rural or underserved communities where access to healthcare is limited, thereby compromising the system's representativeness. Such selection biases may lead to incomplete understandings of distribution, especially for conditions disproportionately affecting marginalized groups. Scalability presents another inherent boundary, as expanding sentinel networks to cover nationwide emergencies demands substantial additional resources and coordination, often rendering the system less effective without integration into active methods. In resource-constrained settings, this limitation can hinder rapid response to large-scale events, confining the approach to ongoing monitoring rather than comprehensive . Furthermore, the effectiveness of sentinel surveillance is highly context-dependent, performing poorly for diseases with low probability of presentation at selected sites or those characterized by rapid, unpredictable spread that outpaces site-based detection. In such scenarios, the system's reliance on sentinel-specific data may fail to signal emerging threats promptly, amplifying risks in dynamic epidemiological environments. Compared to passive systems, which provide broader geographic coverage albeit with lower , sentinel methods thus trade comprehensiveness for precision.

References

  1. https://www.cdc.gov/surv-manual/php/table-of-contents/chapter-19-enhancing-surveillance.html
  2. https://open.oregonstate.education/epidemiology/chapter/surveillance/
  3. https://www.sciencedirect.com/topics/nursing-and-health-professions/sentinel-surveillance
  4. https://www.thelancet.com/journals/lansea/article/PIIS2772-3682(25)00128-3/fulltext
  5. https://www.ncbi.nlm.nih.gov/books/NBK11770/
  6. https://pmc.ncbi.nlm.nih.gov/articles/PMC2486528/
  7. https://gh.bmj.com/content/5/12/e004685
  8. https://bmchealthservres.biomedcentral.com/articles/10.1186/1472-6963-14-424
  9. https://www.who.int/publications/i/item/9789240101432
  10. https://www.who.int/publications-detail-redirect/who-guidelines-on-ethical-issues-in-public-health-surveillance
  11. https://www.cdc.gov/mmwr/preview/mmwrhtml/su6103a3.htm
  12. https://www.emro.who.int/health-topics/influenza/influenza-surveillance.html
  13. https://www.who.int/publications/i/item/9789241549301
  14. https://www.cdc.gov/mmwr/volumes/74/wr/mm7436a3.htm
  15. https://pmc.ncbi.nlm.nih.gov/articles/PMC2732493/
  16. https://www.sciencedirect.com/topics/pharmacology-toxicology-and-pharmaceutical-science/sentinel-surveillance
  17. https://pmc.ncbi.nlm.nih.gov/articles/PMC7780421/
  18. https://iris.who.int/bitstream/handle/10665/272090/PMC5418817.pdf?sequence=1
  19. https://health-policy-systems.biomedcentral.com/articles/10.1186/1478-4505-11-22
  20. https://pmc.ncbi.nlm.nih.gov/articles/PMC9248262/
  21. https://www.paho.org/sites/default/files/2025-01/2015-cha-operational-guidelines-sentinel-sari.pdf
  22. https://www.cdc.gov/flu-global/media/images/2024/10/cdc-flu-surveillance-tool-508-final.pdf
  23. https://wwwnc.cdc.gov/eid/article/15/8/08-1422_article
  24. https://wwwnc.cdc.gov/eid/article/30/11/24-0375_article
  25. https://www.cdc.gov/training-publichealth101/media/pdfs/introduction-to-surveillance.pdf
  26. https://www.emro.who.int/emhj-volume-2-1996/volume-2-issue-1/article6.html
  27. https://archive.cdc.gov/www_cdc_gov/csels/dsepd/ss1978/lesson5/appendixe.html
  28. https://archive.cdc.gov/www_cdc_gov/csels/dsepd/ss1978/lesson5/section4.html
  29. https://ndc.services.cdc.gov/wp-content/uploads/what_data_users_should_know.pdf
  30. https://healthjournalism.org/glossary-terms/active-vs-passive-surveillance/
  31. https://pmc.ncbi.nlm.nih.gov/articles/PMC8389830/
  32. https://femwiki.org/index.php?title=Types_of_Surveillance_System_%28Active_vs_Passive%29
  33. https://health.hawaii.gov/news/covid-19/covid-19-daily-news-digest-april-11-2020/
  34. https://health.hawaii.gov/docd/files/2019/10/Combined_2019-20.pdf
  35. https://www.cdc.gov/mmwr/volumes/69/wr/mm6914e3.htm
  36. https://www.who.int/docs/default-source/coronaviruse/policy-briefs/policy-brief_covid-19_surveillance.pdf
  37. https://www.who.int/initiatives/global-influenza-surveillance-and-response-system
  38. https://www.cdc.gov/flu/php/who-collaboration/index.html
  39. https://pmc.ncbi.nlm.nih.gov/articles/PMC6086842/
  40. https://www.dhhs.nh.gov/programs-services/disease-prevention/infectious-disease-control/infectious-disease-surveillance-0
  41. https://www.cdc.gov/fluview/overview/index.html
  42. https://www.who.int/teams/immunization-vaccines-and-biologicals/immunization-analysis-and-insights/surveillance/surveillance-for-vpds
  43. https://pmc.ncbi.nlm.nih.gov/articles/PMC5853980/
  44. https://www.who.int/teams/health-product-policy-and-standards/standards-and-specifications/norms-and-standards/vaccine-standardization/influenza
  45. https://www.cdc.gov/flu/php/viruses/change.html
  46. https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(22)01741-X/fulltext
  47. https://www.cdc.gov/disaster-epidemiology-and-response/media/pdfs/Disaster_Surveillance_508.pdf
  48. https://pmc.ncbi.nlm.nih.gov/articles/PMC4682212/
  49. https://pmc.ncbi.nlm.nih.gov/articles/PMC7123929/
Add your contribution
Related Hubs
User Avatar
No comments yet.